DrugPatentWatch Database Preview
Biologic Drugs With Dosage Form: INJECTION
Email this page to a colleague
See Plans and PricingDetails for Dosage Type: INJECTION
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sanofi Pasteur Inc. | YF-VAX | yellow fever virus strain 17d-204 live antigen | INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION | 103915 | 1 | 1953-05-22 | Start Trial | |||||
| A-s Medication Solutions | TUBERSOL | tuberculin purified protein derivative | INJECTION, SOLUTION | 103941 | 1 | 1956-08-15 | Start Trial | Commonwealth Scientific & Industrial Research Organisation (Campbell, AU) | 2011-08-02 | search | ||
| A-s Medication Solutions | TUBERSOL | tuberculin purified protein derivative | INJECTION, SOLUTION | 103941 | 1 | 1956-08-15 | Start Trial | Commonwealth Scientific & Industrial Research Organisation (Campbell, AU) | 2006-03-06 | search | ||
| A-s Medication Solutions | TUBERSOL | tuberculin purified protein derivative | INJECTION, SOLUTION | 103941 | 1 | 1956-08-15 | Start Trial | The United States of America as represented by the Secretary of the Navy (Washington, DC) | 2015-11-27 | search | ||
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
